Doyle Mittie 4
4 · Avalo Therapeutics, Inc. · Filed Jul 16, 2024
Insider Transaction Report
Form 4
Doyle Mittie
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-07-15+234,000→ 234,000 totalExercise: $12.65Exp: 2034-07-15→ Common Stock (234,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the Option Shares vest on July 15, 2025 and the remainder of the Option Shares will vest in equal monthly installments over the following three (3) years, provided that Optionee remains an employee of the Company on each such vesting date.